ESR1 and obesity disorder: Chemicals with EA bind to one or more estrogen receptor (ER) subtypes [8,13,14], and can produce various adverse health effects in mammals, such as early menarche, reduced sperm counts and other altered functions of reproductive organs, obesity, and increased rates of some cancers [6,12,15].